3Lebwohl D,Canetta R.Clinical development of platinum complexes in cancer therapy:an historical perspective and an update[J].Eur J Cancer,1998,34(10):1522-1534.
4Woynarowski JM,Faivre S,Herzing MC,et al.Oxaliplatin-induced damage of cellular DNA[J].Mol Pharmacol,2000,58(5):920-927.
5Woynarowski JM,Chapman WG,Napier C,et al.Sequence-andregion-specificity of oxaliplatin adducts in naked and cellular DNA[J].Mol Pharmacol,1998,54(5):770-777.
6Maindrault Goebel F,de-GramoutA,Louver C,et al.High dose intensity oxaliplation added to the simplified bimonthly leucororin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX)[J].Eur J Cancer,2001,37(8):1000-1005.
7Andre' T,Boni C,Mounedji-Boudiaf L,et al.Oxaliplatin,fluorouracil and leucovorin as adjuvant treatment for colon cancer[J].N Engl J Med,2004,350(23):2362-2374.
8Jung GR, Kim KJ, Choi CH, et al. Effect of betulinic acid on anticancer drugresistant colon cancer cells [J]. Basic Clin Pharmacol Toxicol, 2007,101(4):277-285.
9Watson AJ. Apoptosis and colorectal cancer [J]. Gut, 2004,53 (11):1701-1709.
10Martin DA, Elkon KB. Mechanisms of apoptosis [J]. Rheum Dis Clin North Am, 2004,30(3):441 - 454.
1Fang XL. Study the curative effect of advanced stage colon carcinoma treated by L-OHP combined with 5-FU/CF [J]. Chinese Journal of Clinical Rational Drug Use, 2009, 2 ( 13 ) : 8-9.
2Sileri P, Dugo S,Bennavoli D,et al. Metachronous splenicmetastasis from colonic carcinoma five years after surgery: a case report and lit- erature review[J]. South Med J,2009, 102(7):733 -735.
3Sato S,ItamochiH,Kigawa J,et al. Combination chemotherapy of ox- aliplatin and 5-fluorouracilmay be an effective regimen formucinous adenocarcinoma of the ovary: a potential treatment strategy[J]. Cancer- Sci,2009,100(3) :546-551.
4Kweekel DM,Antonini NF,Nortier JW,et al. Explorative study to i- dentify novel candidate genes related to oxaliplatin efficacy and toxi- city using a DNA repair array[J]. Br J Cancer, 2009, 101 (2):357- 362.
